SXTP
Income statement / Annual
Last year (2023), 60 Degrees Pharmaceuticals, Inc.'s total revenue was $253,573.00,
an increase of 13.60% from the previous year.
In 2023, 60 Degrees Pharmaceuticals, Inc.'s net income was -$3.77 M.
See 60 Degrees Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
Operating Revenue |
$253,573.00
|
$223,208.00
|
$1.16 M
|
$2.18 M
|
Cost of Revenue |
$474,550.00 |
$432,370.00 |
$850,742.00 |
$702,989.00 |
Gross Profit |
-$220,977.00 |
-$209,162.00 |
$309,598.00 |
$1.48 M |
Gross Profit Ratio |
-0.87 |
-0.94 |
0.27 |
0.68 |
Research and Development
Expenses |
$691,770.00
|
$237,561.00
|
$318,350.00
|
$438,576.00
|
General & Administrative
Expenses |
$4.24 M
|
$1.30 M
|
$1.12 M
|
$1.46 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$4.24 M
|
$1.30 M
|
$1.12 M
|
$1.46 M
|
Other Expenses |
$0.00 |
-$43,238.00 |
$37,515.00 |
-$121.00 |
Operating Expenses |
$4.93 M |
$1.54 M |
$1.43 M |
$1.85 M |
Cost And Expenses |
$5.41 M |
$1.97 M |
$2.28 M |
$2.55 M |
Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$2.29 M |
$3.99 M |
$3.17 M |
$2.68 M |
Depreciation &
Amortization |
$100,372.00
|
$78,786.00
|
$71,785.00
|
$27,865.00
|
EBITDA |
-$1.43 M
|
-$2.11 M
|
-$1.01 M
|
-$341,169.00
|
EBITDA Ratio |
-5.63 |
-7.68 |
-0.87 |
-0.16 |
Operating Income Ratio
|
-20.33
|
-7.84
|
-0.97
|
-0.19
|
Total Other
Income/Expenses Net |
$1.34 M
|
-$4.43 M
|
-$3.14 M
|
-$2.63 M
|
Income Before Tax |
-$3.81 M |
-$6.18 M |
-$4.26 M |
-$3.05 M |
Income Before Tax Ratio
|
-15.04
|
-27.68
|
-3.67
|
-1.4
|
Income Tax Expense |
$250.00 |
$500.00 |
$1,000.00 |
$1,000.00 |
Net Income |
-$3.77 M |
-$6.18 M |
-$4.25 M |
-$3.03 M |
Net Income Ratio |
-14.85 |
-27.69 |
-3.66 |
-1.39 |
EPS |
-0.95 |
-1.07 |
-0.74 |
-0.52 |
EPS Diluted |
-0.95 |
-1.07 |
-0.74 |
-0.52 |
Weighted Average Shares
Out |
$3.96 M
|
$5.78 M
|
$5.78 M
|
$5.78 M
|
Weighted Average Shares
Out Diluted |
$3.96 M
|
$5.78 M
|
$5.78 M
|
$5.78 M
|
Link |
|
|
|
|